Ceftazidime

Restricted
C difficile risk
High
Oral Bioavailability
N/A
Cost
$25/day

Spectrum Of Activity

Dosing

50 mg/kg/dose IV q12h

0 - 7 days (Postnatal age) Greater than 8 days (Postnatal age) 50 mg/kg/dose IV q12h50 mg/kg/dose IV q8h

0 - 7 days (Postnatal age) Greater than 8 days (Postnatal age) 50 mg/kg/dose IV q8-12h50 mg/kg/dose IV q8h

1gm IV q8h (max: 6 gms/day)

General Information

Pediatrics:

  • Confirmed or suspected pseudomonal infection, febrile neutropenia, or I.D. authorization

  • Empiric treatment for infants <2 months

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.